We describe a spectrophotometric kinetic assay for detecting creatine kinase MB isoenzyme activity in the 1 to 10 U/liter range. The MB isoenzyme was isolated [C/in. Chem. 20, 36 (1974)] and assayed (Rosalki method) with an Abbott ABA-100. Good reproducibility was demonstrated for MB isoenzyme activities near 1 U/liter (CV = 2.6%). Sera with normal or slightly increased total creatine kinase activity were evaluated. Sera of 14 patients with acute myocardial infarction contained, per liter, 84 to 236 U of total creatine kinase activity and 4.6 to 28.0 U of isoenzyme MB activity; corresponding ranges for sera from healthy lab technicians and patients with noncardiac disease were 36 to 277 and 0 to 2.6 U. MB isoenzyme activity for infarction patients rose and fell sharply within three days after the infarction. Atypical time-course patterns, MB isoenzyme activity remaining abnormally great for five days, were observed in serum from patients with prolonged atrial f ibrillation and congestive heart failure or cardiomyopathy; the BB isoenzyme (ito 5 U/liter) was also detected in sera of such patients but was absent in sera from infarction patients. Quantification of column-isolated MB by the assay described is rapid, easy, specific, and extremely sensitive for measuring MB in the 1 to 10 U/liter range. 
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We describe a spectrophotometric kinetic assay for detecting creatine kinase MB isoenzyme activity in the 1 to 10 U/liter range. The MB isoenzyme was isolated [C/in. Chem. 20, 36 (1974) ] and assayed (Rosalki method) with an Abbott ABA-100. Good reproducibility was demonstrated for MB isoenzyme activities near 1 U/liter (CV = 2.6%). Sera with normal or slightly increased total creatine kinase activity were evaluated. Sera of 14 patients with acute myocardial infarction contained, per liter, 84 to 236 U of total creatine kinase activity and 4.6 to 28.0 U of isoenzyme MB activity; corresponding ranges for sera from healthy lab technicians and patients with noncardiac disease were 36 to 277 and 0 to 2.6 U. MB isoenzyme activity for infarction patients rose and fell sharply within three days after the infarction. Atypical time-course patterns, MB isoenzyme activity remaining abnormally great for five days, were observed in serum from patients with prolonged atrial f ibrillation and congestive heart failure or cardiomyopathy; the BB isoenzyme (ito 5 U/liter) was also detected in sera of such patients but was absent in sera from infarction patients. Quantification of column-isolated MB by the assay described is rapid, easy, specific, and extremely sensitive for measuring MB in the 1 to 10 U/liter range. 
Materials and Methods

Sample Preparation
Sera with CK activitiesup to threefold normal were obtained from a general hospital population. Total CK and CK isoenzyme activities were measured immediately after centrifugation of the blood sample.
Column Chromatography
One milliliter of serum was applied to a mini-column of DEAE-Sephadex A-SO, prepared as described previously (1) , except that the elution scheme for separation of MM, MB, and BB was slightly modified as follows.
After Routinely, only the MB isoenzyme fractions 6, 7, 8, and 9 and one of the BB isoenzyme fractions, fraction 11, were assayed. Activity in fraction 6 was used to check for any carry over of MM isoenzyme.
As a rule, fraction 6 was without signifi- cant activityunless CK samples with activity near 3000 U/literwere applied to the column. Activity in fractions7, 8, and 9 was summed and reported as U/ literof MB isoenzyme or as percentage of total CK activity. BB isoenzyme in fractions10 and 12 was assayed only when BB activity was detected in fraction 11. Results were returned to the patient'schart the same day, usually within 6 h. 
Results
Sensitivity
tivities.
Total method reliability (column and assay) for detection of MB isoenzyme in a normal serum pool (frozen) was followed by daily analysis. Mean (n = 21), standard deviation, and coefficient of variation for the normal serum pool were 0.79 U/liter,0.17 U/liter, and 21.1%, respectively.Daily analysis of an abnormal serum pool (frozen), collected from patients with myocardial infarction, yielded a mean (n = 19) of 56.6 U/liter,a standard deviation of 5.7 U/liter,and a coefficient of variation of 10.0%. Figure 1 illustrates the typical ion-exchange chromatographic behavior of the MM and MB isoenzymes. The pattern was obtained by applying to the column 1 ml of serum (238 U/liter) from a patient who recently had a myocardial infarction. MB isoenzyme activityof 24.0 U/liter (10.0% of totalCK) was recovered in the 200 mmol/liter sodium chloride eluate and MM isoenzyme activityof 215 U/liter (90% of total CK) in the 100 mmol/liter sodium chloride eluate. Table 2 shows the results of total CK and MB isoenzyme analysisin sera of healthy laboratory techni- Table 2 . The sera we analyzed were collected during peak activity of total CK. A range of 4.6 to 28.0 U/liter for MB isoenzyme was observed. Expressed in terms of percentage of total activity, a range of 4.5 to 19.9% was calculated for MB. BB isoenzyme was not detected. Table  2 also shows values for and diagnosis of 10 patients without heart disease in whom serum CK activitywas slightly increased (152-277 U/liter). The range for thisgroup was 0 to 2.6 U/literfor MB isoenzyme. MB expressed as a percentage of total CK never exceeded 2%. Again, BB activitywas absent. Figure 2 shows changes with time for totalCK and MB in a typical patient with myocardial infarction. Total CK and MB parallel one another during the early stages of post-infarction; both were at their peak values 24 h after onset of chest pain. MB had returned to baseline values by 48 h post-infarction, total CK by 72 h. Although total CK remained within normal limits(62-120 U/liter), MB isoenzyme activity was 10-foldnormal 24 h after infarction. We saw typical changes of this sort in MB isoenzyme activityin severalpatients with prolonged atrial fibrillation and congestive heart failureand in one patient with cardiomyopathy. Figure 3 depicts the typical behavior of MB isoenzyme for five consecutive days in these patients.
Although total CK remained within normal limits, MB isoenzyme exhibited abnormally high values for the five days in which they were measured, and in none of these patients could a clear peaking for MB activity be identified. Small activities of BB isoenzyme (1) (2) (3) (4) (5) U/liter) were also detected. There may be other conditions, such as congestive heart failureor cardiomyopathy, where a small but continuous degree of myocardial cell destruction occurs. In fact, using the present sensitive technique, we have found persistent slight elevation of MB in the sera of some patients with these diagnoses (Figure 3) . One experimental study #{149}(11) that supports this supposition demonstrated the release of total CK from the coronary sinus during rapid atrialpacing.
Discussion
In addition to patients with prolonged atrial fibrillation, congestive heart failure, and cardiomyopathy, abnormally high MB isoenzyme activity has been detected in patients with muscular dystrophy (12, 13) and polymyositis (14) . Although all of these conditions give MB values that could lead to a mis-diagnosisof acute myocardial infarction,they appear to be easily distinguishablewhen MB isoenzyme is determined daily and changes with time are followed (Figures 2 and 3 
